Parathyroid hormone and thyrocalcitonin: their mode of action and regulation.
D000236:Adenoma / Q000652:urine; D000262:Adenylyl Cyclases; D000328:Adult; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D001862:Bone Resorption / Q000187:drug effects; D001842:Bone and Bones / Q000201:enzymology; D002116:Calcitonin / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D002118:Calcium / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D002128:Calcium Metabolism Disorders / Q000503:physiopathology; D000242:Cyclic AMP / Q000652:urine; D004285:Dogs; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D006965:Hyperplasia / Q000378:metabolism; D007011:Hypoparathyroidism / Q000503:physiopathology / Q000652:urine; D007037:Hypothyroidism / Q000652:urine; D007263:Infusions, Parenteral; D007408:Intestinal Absorption / Q000187:drug effects; D007668:Kidney / Q000201:enzymology; D007669:Kidney Calculi / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000652:urine; D010024:Osteoporosis / Q000503:physiopathology; D010279:Parathyroid Diseases / Q000378:metabolism; D010281:Parathyroid Hormone / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D010282:Parathyroid Neoplasms / Q000652:urine
D010281:Parathyroid Hormone; D002116:Calcitonin; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D006909:Hydroxyproline; D002118:Calcium